Compare Marriott International Inc (MAR) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marriott International Inc vs Moderna, Inc. — how do they compare? Marriott International Inc trades at $349.48 (market cap $91.14B), while Moderna, Inc. trades at $60.83 (market cap $24.18B). The key difference: Marriott International Inc is far larger — about 3.8× Moderna, Inc.'s market cap, and Marriott International Inc pays a 0.84% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MAR | MRNA | |
|---|---|---|
Market Cap | $91.14B | $24.18B |
Sector | Consumer Cyclical | Health |
52-Week High | $402.54 | $81.80 |
52-Week Low | $259.04 | $22.36 |
Enterprise Value | $108.45B | $20.33B |
Dividend Yield | 0.84% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Marriott International Inc
Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.
Read more on MAR →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
